ATE286391T1 - Synergistische zusammensetzung zur krebsbehandlung - Google Patents

Synergistische zusammensetzung zur krebsbehandlung

Info

Publication number
ATE286391T1
ATE286391T1 AT00904990T AT00904990T ATE286391T1 AT E286391 T1 ATE286391 T1 AT E286391T1 AT 00904990 T AT00904990 T AT 00904990T AT 00904990 T AT00904990 T AT 00904990T AT E286391 T1 ATE286391 T1 AT E286391T1
Authority
AT
Austria
Prior art keywords
cancer treatment
synergistic composition
synergistic
composition
cancer
Prior art date
Application number
AT00904990T
Other languages
English (en)
Inventor
Cristina Geroni
Marina Ripamonti
Michele Caruso
Antonino Suarato
Original Assignee
Pharmacia Italia Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Italia Spa filed Critical Pharmacia Italia Spa
Application granted granted Critical
Publication of ATE286391T1 publication Critical patent/ATE286391T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT00904990T 1999-02-25 2000-01-31 Synergistische zusammensetzung zur krebsbehandlung ATE286391T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9904386.1A GB9904386D0 (en) 1999-02-25 1999-02-25 Antitumour synergistic composition
PCT/EP2000/000746 WO2000050033A2 (en) 1999-02-25 2000-01-31 Anti-tumor synergetic composition

Publications (1)

Publication Number Publication Date
ATE286391T1 true ATE286391T1 (de) 2005-01-15

Family

ID=10848513

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00904990T ATE286391T1 (de) 1999-02-25 2000-01-31 Synergistische zusammensetzung zur krebsbehandlung

Country Status (17)

Country Link
US (1) US6593303B1 (de)
EP (1) EP1169035B1 (de)
JP (1) JP2002537334A (de)
KR (1) KR20010102402A (de)
CN (1) CN1341020A (de)
AR (1) AR022719A1 (de)
AT (1) ATE286391T1 (de)
AU (1) AU774393B2 (de)
BR (1) BR0008454A (de)
CA (1) CA2361828A1 (de)
DE (1) DE60017250D1 (de)
GB (1) GB9904386D0 (de)
HK (1) HK1042249A1 (de)
MY (1) MY125222A (de)
NZ (1) NZ513352A (de)
WO (1) WO2000050033A2 (de)
ZA (1) ZA200106210B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9916882D0 (en) * 1999-07-19 1999-09-22 Pharmacia & Upjohn Spa Antitumor synergistic composition
CZ20022216A3 (cs) * 2001-07-02 2003-05-14 Warner-Lambert Company Kombinační chemoterapie
CN103183812B (zh) 2005-04-22 2016-03-02 三菱化学株式会社 来自生物质资源的聚酯及其制造方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4177263A (en) * 1972-02-28 1979-12-04 Research Corporation Anti-animal tumor method
JPH02157291A (ja) * 1988-12-07 1990-06-18 Morishita Pharmaceut Co Ltd アントラサイクリン系抗生物質のｎ−ホルミルアミノ酸複合体およびその白金錯体組成物
GB9114549D0 (en) 1991-07-05 1991-08-21 Erba Carlo Spa Mono and bis alkylamino-anthracyclines
US5294538A (en) 1991-11-18 1994-03-15 Cold Spring Harbor Labs. Method of screening for antimitotic compounds using the CDC25 tyrosine phosphatase
FR2697752B1 (fr) * 1992-11-10 1995-04-14 Rhone Poulenc Rorer Sa Compositions antitumorales contenant des dérivés du taxane.
GB9325417D0 (en) 1993-12-13 1994-02-16 Erba Carlo Spa 3'- aziridino-anthracycline derivatives
JPH07188034A (ja) * 1993-12-28 1995-07-25 Nisshin Flour Milling Co Ltd エンドセリン変換酵素阻害剤
DE69519300T2 (de) * 1994-08-08 2001-05-31 Debiopharm S.A., Lausanne Stabiles arzneimittel enthaltend oxaliplatin
US5919816A (en) * 1994-11-14 1999-07-06 Bionumerik Pharmaceuticals, Inc. Formulations and methods of reducing toxicity of antineoplastic agents
ES2151277T3 (es) * 1996-05-22 2000-12-16 Protarga Inc Composiciones que comprenden conjugados de acido cis-docosahexaenoico y taxotere.
KR20010052616A (ko) * 1998-06-05 2001-06-25 파라비 레이 텍사피린 콘쥬게이트 및 그 용도

Also Published As

Publication number Publication date
EP1169035B1 (de) 2005-01-05
BR0008454A (pt) 2002-01-29
NZ513352A (en) 2003-08-29
WO2000050033A2 (en) 2000-08-31
ZA200106210B (en) 2002-10-28
KR20010102402A (ko) 2001-11-15
US6593303B1 (en) 2003-07-15
CA2361828A1 (en) 2000-08-31
MY125222A (en) 2006-07-31
AR022719A1 (es) 2002-09-04
WO2000050033A3 (en) 2000-12-21
AU2668100A (en) 2000-09-14
CN1341020A (zh) 2002-03-20
AU774393B2 (en) 2004-06-24
DE60017250D1 (de) 2005-02-10
HK1042249A1 (zh) 2002-08-09
GB9904386D0 (en) 1999-04-21
EP1169035A2 (de) 2002-01-09
JP2002537334A (ja) 2002-11-05

Similar Documents

Publication Publication Date Title
ATE279190T1 (de) Synergistische zusammensetzungen zur krebsbehandlung
ATE430570T1 (de) Synergistische kombinationstherapie zur krebsbehandlung
AU6147401A (en) Compositions and methods for the treatment of cancer
GB0401948D0 (en) Topical composition for treating pain
DE60211740D1 (de) Zusammensetzung zur saatgutbehandlung
DK1250152T3 (da) Synergistisk sammensætning indeholdende hyaluronsyre til behandling af cancer
DE60223576D1 (de) Hautbehandlungszusammensetzung
IL148579A0 (en) Oncolytic combinations for the treatment of cancer
EP1461047A4 (de) Zusammensetzungen und verfahren zur behandlung von tieren
DE60135248D1 (de) Immuntherapeutische kombinationen zur tumorbehandlung
DE60042606D1 (de) Anti-angiogener zellulärer wirkstoff zur krebsbehanldung
HUP0500199A3 (en) Pharmaceutical composition comprising arsenite for the treatment of malignancy
DE10081194D2 (de) Darreichungsform zur Applikation in Körperöffnungen
GB2354944B (en) Skin treatment compositions
ATE286391T1 (de) Synergistische zusammensetzung zur krebsbehandlung
AU2003298708A8 (en) Gpc99 and gpc99a: methods and compositions for treating cancer
GB0026015D0 (en) Cancer treatment
IL148815A0 (en) Substituted pyrroles as antiproliferative agents for the treatment of cancer
HU9902296D0 (en) Pharmaceutical composition for treating caltification
AU2002360454A8 (en) Methods and compositions for treating cancer
AU2003295604A8 (en) Gpc15: methods and compositions for treating cancer
HRPK20020201B1 (en) Pharmaceutical compositions for treating psoriasis
SI2105135T1 (sl) Farmacevtski sestavki za zdravljenje raka
LV12535A (lv) Treatment having antioxidant effect for stregthening capillars
NO995276D0 (no) Behandlingsbenk

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties